RxSight (RXST) Interest & Investment Income (2020 - 2026)
RxSight (RXST) posted Interest & Investment Income of $2.0 million for Q1 2026, down 10.98% on a QoQ basis from $2.2 million in Q4 2025, and down 22.09% year-over-year from $2.5 million in Q1 2025.
RxSight (RXST) Interest & Investment Income (2020 - 2026) Analysis & Trends
RxSight's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- Quarterly Interest & Investment Income fell 22.09% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (down 15.56% YoY) and the FY2025 annual result came in at $9.3 million, down 1.5% from the prior year.
- Interest & Investment Income was $2.0 million for Q1 2026 at RxSight, down from $2.2 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.9 million in Q3 2024 and bottomed at $46000.0 in Q1 2022.
- A 5-year average of $1.7 million and a median of $1.8 million in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income soared 8260.0% — and 2026, when it fell 22.09%.
- RxSight's Interest & Investment Income stood at $836000.0 in 2022, then jumped by 98.68% to $1.7 million in 2023, then surged by 62.97% to $2.7 million in 2024, then declined by 18.91% to $2.2 million in 2025, then declined by 10.98% to $2.0 million in 2026.
- Business Quant data shows RXST's Interest & Investment Income at $2.0 million in Q1 2026, $2.2 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | RxSight | 234.21 Mn | -184.00 Mn | 23.50 Mn | 1.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.95 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | 2.38 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Dec 31, 2024 | 2.71 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 2.28 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 1.66 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 1.78 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 836,000.00 |
| Sep 30, 2022 | 439,000.00 |
| Jun 30, 2022 | 196,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 11,000.00 |
| Jun 30, 2021 | 15,000.00 |